Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Remote sensor may let heart failure patients Self-Tune diuretics

NCT ID NCT07743125

Disease control Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This study tests whether adults with heart failure who have an implanted pulmonary artery pressure sensor can safely adjust their own diuretic (water pill) doses. Participants follow a simple guide to change their medication based on daily pressure readings sent to their phone or patient portal. The study tracks safety events like hospitalizations and kidney issues, as well as how well the approach controls heart failure symptoms over 90 days.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Shared-management diuretic titration guided by remote pulmonary artery pressure monitoring
What this could lead to
If successful, this could empower heart failure patients to manage their own fluid levels at home, potentially reducing hospitalizations and improving quality of life.
What could go wrong
This is a small, early feasibility study, so results may not apply broadly. There are risks of over- or under-diuresis, leading to kidney injury or electrolyte imbalances.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

21 people

The number who actually took part.

Started

Jan 2026

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (prospective arm participants must meet ALL of 1-7; retrospective cohort inclusion limited to criterion 1): 1. Currently implanted with and actively transmitting remote pulmonary artery pressures using the CardioMEMS HF system and exclusively managed by the Froedtert Menomonee Falls Cardiovascular Team according to previously published hemodynamic treatment algorithm. 2. Provision of signed and dated informed consent 3. Stated willingness to comply with study procedure and mandates and remain available for the duration of the study period of 90 days. 4. Males and females; Ages 40-90 5. Documented diagnosis of heart failure (regardless of ejection fraction) with volume related symptoms managed with a loop diuretic. 6. Willingness to participate in a shared-management strategy 7. Access to necessary resources for participating in a technology-based intervention (i.e., Epic MyChart via computer, smartphone, or tablet with internet access) Exclusion Criteria (any ONE excludes): 1. Allergy/intolerance to loop or thiazide diuretics. 2. Oliguria/anuria either acute or chronic. 3. Chronic kidney disease Stage IV, V, or undergoing renal replacement therapy. 4. Transplant organ recipient 5. Chronic immunosuppressant therapy 6. Idiopathic fluid collections (for example ascites, pulmonary or pericardial effusions) 7. Currently undergoing chemotherapy for malignancy or having received chemotherapeutic treatment in the past 12 months. 8. Hospice plan of care or prior designation of hospice plan of care within 12 months. 9. Advanced heart failure designation with or without durable mechanical circulatory support. 10. Technically or medically illiterate precluding use of Epic MyChart application. 11. Blister packaged medications 12. Resident of group/assisted living facility. 13. Either partially or completely dependent on social/family support for IADLs/ADLs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Heart failure are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Heart failure

Contacts and locations

Locations

  • Froedtert Menomonee Falls Hospital

    Menomonee Falls, Wisconsin, 53051, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.